IRIS
ULIVELLI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.857
EU - Europa 5.323
AS - Asia 832
AF - Africa 49
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 6
Totale 12.086
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.828
GB - Regno Unito 1.932
IE - Irlanda 915
IT - Italia 565
CN - Cina 502
SE - Svezia 499
UA - Ucraina 442
RU - Federazione Russa 266
FR - Francia 253
DE - Germania 216
SG - Singapore 147
FI - Finlandia 122
VN - Vietnam 63
TR - Turchia 59
CI - Costa d'Avorio 44
ES - Italia 33
CA - Canada 24
BE - Belgio 22
IN - India 17
HK - Hong Kong 12
AT - Austria 11
AU - Australia 9
CZ - Repubblica Ceca 8
EU - Europa 7
GR - Grecia 7
NL - Olanda 7
IL - Israele 5
BR - Brasile 4
MN - Mongolia 4
PK - Pakistan 4
PL - Polonia 4
RO - Romania 4
IR - Iran 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
JP - Giappone 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.086
Salva come PNG Salva come JPEG
Città #
Southend 1.830
Fairfield 976
Dublin 904
Chandler 522
Ashburn 505
Woodbridge 452
Wilmington 393
Jacksonville 364
Cambridge 340
Seattle 336
Houston 333
Ann Arbor 243
Siena 178
Princeton 159
Menlo Park 138
Beijing 115
Nanjing 113
Singapore 102
Dong Ket 61
Helsinki 60
San Diego 60
Boardman 59
San Mateo 55
Dearborn 50
Abidjan 44
Nanchang 44
Izmir 40
Norwalk 37
Moscow 33
Málaga 31
Shanghai 31
New York 28
Shenyang 27
Tianjin 27
Florence 26
London 24
Milan 23
Brussels 22
Triggiano 20
Jinan 19
Fremont 18
Changsha 17
Rome 16
Düsseldorf 15
Kunming 15
Ottawa 13
Jiaxing 12
Hebei 11
Vienna 11
Zhengzhou 11
Guangzhou 10
San Francisco 10
Washington 10
Cisano Bergamasco 9
Kilburn 9
Los Angeles 9
Hangzhou 8
Ningbo 8
Berlin 7
Pune 7
Santa Clara 7
Arezzo 6
Falls Church 6
Lappeenranta 6
Pisa 6
Tappahannock 6
Toronto 6
Brno 5
Carpi 5
Edinburgh 5
Lanzhou 5
Livorno 5
Monte 5
Pistoia 5
Redwood City 5
Sacramento 5
Turin 5
Anguillara Sabazia 4
Ankara 4
Cedar Knolls 4
Central 4
Hefei 4
Hong Kong 4
Islington 4
Monte San Savino 4
Munich 4
Sergnano 4
Ulan Bator 4
Verona 4
Villacidro 4
Amsterdam 3
Bitonto 3
Boston 3
Canberra 3
Chiswick 3
Delhi 3
Figline Valdarno 3
Fort Worth 3
Groningen 3
Hounslow 3
Totale 9.225
Salva come PNG Salva come JPEG
Nome #
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 242
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 230
Multiple sclerosis incidence in Tuscany from administrative data 214
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 206
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 205
Multiple sclerosis spatial cluster in Tuscany 202
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 191
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 184
Multiple sclerosis incidence in Tuscany from administrative data 182
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 181
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 178
The Italian Multiple Sclerosis Register 177
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 173
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 169
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 165
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 163
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 160
Increasing prevalence of multiple sclerosis in Tuscany, Italy 159
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 157
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 153
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 151
A clinically silent, but severe, duodenal complication of duodopa infusion 148
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 148
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 146
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 145
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 145
Antiparkinsonian drugs and visual hallucinations 144
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 141
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 141
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 139
The olfactory side of Parkinson disease: Relevance for clinical practice 138
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 138
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 135
Reliability of administrative data for the identification of Parkinson's disease cohorts 134
Citalopram as treatment of depression in patients with epilepsy 132
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 132
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 132
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 132
The heart side of brain neuromodulation 131
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 131
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 131
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 127
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 127
Clinical evidence of fluconazole-induced carbamazepine toxicity 126
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 126
Primary intraventricular haemorrhage in adults 126
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 125
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 124
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 123
Distinct olfactory cross-modal effects on the human motor system 123
Temporal dynamics of memory trace formation in the human prefrontal cortex 123
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 122
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 122
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 121
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 120
Seizures after spontaneous supratentorial intracerebral hemorrhage 120
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 119
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 118
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 118
La distribuzione geografica della sclerosi multipla in Toscana 117
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 116
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 114
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 114
null 112
Feasibility of TMS in patients with new generation cochlear implants 112
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 110
Somatosensory processing during movement observation in humans 110
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 110
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 108
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 108
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 108
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 107
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 106
null 106
Mortality of Parkinson’s disease in Italy from 1980 to 2015 106
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 105
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 102
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 98
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 97
Association of celiac disease in patients with multiple sclerosis in Tuscany 89
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 89
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 82
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 82
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 82
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 76
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 76
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 72
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 70
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 69
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 68
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 65
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 59
Pisa syndrome in Parkinson disease 55
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 53
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 44
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 42
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 29
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 29
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 29
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 25
Totale 12.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.685
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.079 0 0 156 426 154 225 216 326 212 170 66 128
2020/20212.096 92 189 57 186 126 228 173 289 227 170 181 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.393 64 27 112 82 42 357 481 55 13 21 43 96
2024/2025473 54 162 257 0 0 0 0 0 0 0 0 0
Totale 12.349